Michael A Metzger
CIK 1507220 · Chief Executive Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.85M
Companies
6
Total Filings
56
Lifetime Open-Market Net
-$15.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNDX | Chief Executive Officer | 484,843 | $18.25 | $8.85M | -$14.62M | 32 | 2026-06-02 |
| PYXS | Director | — | $1.76 | — | $0 | 3 | 2026-03-25 |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | 4,500 | $9.09 | $40.9K | -$1.20M | 13 | 2023-06-26 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | President & CEO | — | — | — | $0 | 2 | 2015-02-20 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | President and COO | — | — | — | $0 | 1 | 2013-12-20 |
| RESPONSE GENETICS INC (RGDX) Delisted | Director | 1,000 | — | — | $1.5K | 5 | 2012-08-01 |
Recent Filings · Page 2 of 6
56 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-07 | SNDX | Grant (A) | +149,500 | $0 | EDGAR |
| 2024-06-10 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2024-02-09 | SNDX | Grant (A) | +146,250 | $0 | EDGAR |
| 2023-06-26 | CTI BIOPHARMA CORP (CTIC) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-04-07 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-08 | SNDX | Mixed | — | -$126.7K | EDGAR |
| 2023-02-03 | SNDX | Grant (A) | — | $0 | EDGAR |
| 2022-11-10 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | — | -$424.0K | EDGAR |
| 2022-10-07 | SNDX | Mixed | — | -$268.2K | EDGAR |
| 2022-10-04 | SNDX | Mixed | — | -$548.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.